Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist
Abstract: Treatment decisions for aggressive non-Hodgkin lymphoma in elderly and frail patients still remain challenging. The heterogeneity of elderly patients consists of various physical and psychological states, coexisting comorbidities as well as frailty and socioeconomic status. Comprehensive geriatric assessment in elderly patients is efficient and necessary for risk stratification to identify fit patients without cardiac comorbidities who can tolerate curative treatment with rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) and those who are not suitable for a standard regimen. If anthracycline-containing therapy is not feasible, alternative treatment options have to be carefully evaluated and individual risk factors have to be considered
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Therapeutic advances in hematology. - 12 (2021) , 204062072199648, ISSN: 2040-6215
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2021
- DOI
-
10.1177/2040620721996484
- URN
-
urn:nbn:de:bsz:25-freidok-1948155
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schmittlutz, Katrin Carmen
- Marks, Reinhard
- Universität
Time of origin
- 2021
Other Objects (12)
Radiotherapy for Hodgkin lymphoma
Developing a prognostic risk score for patients with newly diagnosed aggressive Non-Hodgkin Lymphoma : clinical and statistical issues
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Transcriptional profiling of aggressive lymphoma
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Health-related quality of life in patients with indolent and aggressive non-Hodgkin lymphoma
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age
HSP90 as a novel target therapy for the treatment of Hodgkin’s Lymphoma
Leukemia and non-Hodgkin lymphoma
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
Non-Hodgkin-Lymphome : Cytologie u. Cytochemie = Non-Hodgkin's lymphoma
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
Radiotherapy for Hodgkin lymphoma
Developing a prognostic risk score for patients with newly diagnosed aggressive Non-Hodgkin Lymphoma : clinical and statistical issues
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Transcriptional profiling of aggressive lymphoma
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Health-related quality of life in patients with indolent and aggressive non-Hodgkin lymphoma
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age
HSP90 as a novel target therapy for the treatment of Hodgkin’s Lymphoma
Leukemia and non-Hodgkin lymphoma
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
Non-Hodgkin-Lymphome : Cytologie u. Cytochemie = Non-Hodgkin's lymphoma
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
Radiotherapy for Hodgkin lymphoma
Developing a prognostic risk score for patients with newly diagnosed aggressive Non-Hodgkin Lymphoma : clinical and statistical issues
Autologous bone marrow transplantation for Hodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma
Transcriptional profiling of aggressive lymphoma
Genetically engineered CD4+ T cells for immunotherapy of Hodgkin lymphoma
Health-related quality of life in patients with indolent and aggressive non-Hodgkin lymphoma
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age
HSP90 as a novel target therapy for the treatment of Hodgkin’s Lymphoma
Leukemia and non-Hodgkin lymphoma
Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
Non-Hodgkin-Lymphome : Cytologie u. Cytochemie = Non-Hodgkin's lymphoma